|
|
|
Insider
Information: |
Birner Hubert |
Relationship: |
Director, 10% Owner |
City: |
Northbrook |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
12,680 |
|
Indirect Shares
|
5,545,550 |
|
|
Direct
Value |
$679 |
|
|
Indirect Value
|
$53,079,742 |
|
|
Total
Shares |
5,558,230 |
|
|
Total
Value |
$53,080,421 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Horizon Pharma, Inc. |
HZNP |
Director |
|
0 |
2011-08-02 |
1,672,158 |
Premium* |
|
Argos Therapeutics Inc |
ARGS |
Director |
2016-12-31 |
12,680 |
2016-06-29 |
1,930,333 |
Premium* |
|
Protara Therapeutics, Inc |
TARA |
Director, 10% Owner |
2014-10-27 |
0 |
2014-10-27 |
1,943,059 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARGS |
Argos Therapeutics Inc |
Director |
|
2016-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,571 |
12,680 |
0 |
- |
|
ARGS |
Argos Therapeutics Inc |
Director |
|
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,521 |
9,109 |
0 |
- |
|
ARGS |
Argos Therapeutics Inc |
Director |
|
2016-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,854 |
5,588 |
0 |
- |
|
ARGS |
Argos Therapeutics Inc |
Director |
|
2016-06-29 |
4 |
B |
$0.00 |
$0 |
I/I |
275,545 |
1,930,333 |
2.02 |
- |
|
ARGS |
Argos Therapeutics Inc |
Director |
|
2016-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,734 |
2,734 |
0 |
- |
|
ARGS |
Argos Therapeutics Inc |
Director |
|
2016-03-14 |
4 |
B |
$0.00 |
$0 |
I/I |
183,697 |
1,654,788 |
2.02 |
- |
|
TARA |
Protara Therapeutics, Inc |
Director |
|
2014-10-27 |
4 |
OE |
$4.60 |
$719,998 |
I/I |
156,443 |
1,943,059 |
0 |
- |
|
TARA |
Protara Therapeutics, Inc |
Director |
|
2014-10-27 |
4 |
A |
$0.00 |
$0 |
I/I |
1,486,616 |
1,786,616 |
0 |
- |
|
TARA |
Protara Therapeutics, Inc |
Director |
|
2014-10-27 |
4 |
B |
$10.00 |
$3,000,000 |
I/I |
300,000 |
300,000 |
2.25 |
- |
|
ARGS |
Argos Therapeutics Inc |
Director |
|
2014-02-12 |
4 |
B |
$8.00 |
$318,984 |
I/I |
39,873 |
1,471,091 |
2.25 |
- |
|
ARGS |
Argos Therapeutics Inc |
Director |
|
2014-02-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,431,218 |
1,431,218 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2011-08-02 |
4 |
B |
$9.00 |
$1,405,458 |
I/I |
156,162 |
704,691 |
2.1 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2011-08-02 |
4 |
A |
$0.00 |
$1,135,395 |
I/I |
743,789 |
582,411 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2011-07-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
67,246 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|